- Home
- PPBT vs REBN Comparison
PPBT vs REBN Comparison
Compare PPBT & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- REBN
- Stock Information
- Founded
- PPBT 2010
- REBN 2015
- Country
- PPBT Israel
- REBN United States
- Employees
- PPBT N/A
- REBN N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- REBN Restaurants
- Sector
- PPBT Health Care
- REBN Consumer Discretionary
- Exchange
- PPBT Nasdaq
- REBN Nasdaq
- Market Cap
- PPBT 6.2M
- REBN 12.8M
- IPO Year
- PPBT N/A
- REBN 2022
- Fundamental
- Price
- PPBT $2.40
- REBN $2.75
- Analyst Decision
- PPBT Strong Buy
- REBN
- Analyst Count
- PPBT 1
- REBN 0
- Target Price
- PPBT $33.00
- REBN N/A
- AVG Volume (30 Days)
- PPBT 20.0K
- REBN 60.7K
- Earning Date
- PPBT 08-15-2025
- REBN 08-18-2025
- Dividend Yield
- PPBT N/A
- REBN N/A
- EPS Growth
- PPBT N/A
- REBN N/A
- EPS
- PPBT N/A
- REBN N/A
- Revenue
- PPBT N/A
- REBN $6,103,732.00
- Revenue This Year
- PPBT N/A
- REBN $335.98
- Revenue Next Year
- PPBT N/A
- REBN N/A
- P/E Ratio
- PPBT N/A
- REBN N/A
- Revenue Growth
- PPBT N/A
- REBN 3.38
- 52 Week Low
- PPBT $2.00
- REBN $1.03
- 52 Week High
- PPBT $13.95
- REBN $8.30
- Technical
- Relative Strength Index (RSI)
- PPBT 47.27
- REBN 57.62
- Support Level
- PPBT $2.35
- REBN $2.61
- Resistance Level
- PPBT $2.58
- REBN $3.16
- Average True Range (ATR)
- PPBT 0.12
- REBN 0.20
- MACD
- PPBT 0.01
- REBN 0.06
- Stochastic Oscillator
- PPBT 43.75
- REBN 68.46
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.